Oct. 4, 2024
The American College of Radiology® (ACR®) is now participating in the U.S. Food and Drug Administration (FDA) Total Product Life Cycle Advisory Program (TAP) pilot, corresponding with the expansion of the program to include radiology devices. The goal of the collaboration is to increase access for radiologists and their patients to safe, effective and clinically meaningful radiology device innovations, including — but not limited to — certain artificial intelligence (AI)-enabled software devices and other cutting-edge technologies.

The TAP pilot is an engagement program focused on providing innovators of various sizes with strategic input in the areas of patient engagement, clinical evidence development, clinical practice and new technology adoption, and reimbursement. The program is initially limited to certain devices with “Breakthrough Device” designations. It expanded from cardiology device exclusivity to include neurology, ophthalmology and radiology devices.

More information about initiatives to advance radiology AI is on the ACR Data Science Institute® website. For questions about digital health regulatory policy, contact Michael Peters, ACR Senior Director, Government Affairs.

Related ACR News

  • Capitol Hill Day May 7 Offers Direct Voice With Congress

    ACR 2025 attendees will have the opportunity to meet with members of Congress and congressional staff May 7, during the College’s Capitol Hill Day in Washington.

    Read more
  • National Correct Coding Initiative Quarterly Updates Released

    CMS released quarterly National Correct Coding Initiative Procedure-to-Procedure, Medically Unlikely Edits and Add-on Code edits that take effect July 1.

    Read more
  • CMS Extends MIPS Submission Deadline

    CMS announced that the Extreme and Uncontrollable Circumstances application for clinicians participating in the 2024 MIPS will be reopened due to the ongoing national IV fluid shortage.

    Read more